GlassScriptPhysician profile
Dianne Kreptowski
NPI 1679681282
$2,711.05
in general payments reported to CMS, 2019-2025
23 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,143 · 2020: $345 · 2021: $128 · 2022: $196 · 2023: $120 · 2024: $296 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $516.76 | 2019-2025 | Jardiance, Synjardy |
| Pfizer INC. | $349.51 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $341.24 | 2019-2025 | Breztri, Airsupra |
| Novo Nordisk INC | $254.61 | 2019-2022 | |
| Amarin Pharma, INC. | $216.35 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $215.01 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Lilly USA, LLC | $162.56 | 2019-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $110.62 | 2020-2022 | |
| Sanofi Pasteur INC. | $100.20 | 2019 | |
| Abbvie INC. | $91.24 | 2019-2024 | |
| Amgen INC. | $77.09 | 2019-2020 | |
| Glaxosmithkline, LLC. | $47.52 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $43.95 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.30 | 2019 | |
| Axsome Therapeutics, INC. | $25.76 | 2025 | Auvelity |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.31 | 2019 | |
| Dexcom, INC. | $17.85 | 2023 | Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $16.82 | 2019 | |
| Astellas Pharma US INC | $16.10 | 2020 | |
| Eisai INC. | $15.86 | 2021 | |
| Exact Sciences Corporation | $15.57 | 2025 | Cologuard Collection Kit |
| Ironshore Pharmaceuticals INC. | $13.44 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dianne Kreptowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.